Mira Pharmaceuticals, Inc. (MIRA) Financial Statements
Industry: Pharmaceutical Preparations
Net income was -$10.4M, or -$1.35 per diluted share. Operating activities generated -$4.7M of cash, leaving -$4.7M of free cash flow. At fiscal year end, Mira Pharmaceuticals held $11.1M in total assets against $702,068 in total liabilities, including $6.3M of cash and equivalents.
Open the full interactive Mira Pharmaceuticals financials → Quarterly statements, key ratios, valuation history and price charts.
Mira Pharmaceuticals Key Stats
| Share Price | $0.67 |
|---|---|
| Market Cap | $28.0M |
| 52-Week Range | $0.61 – $1.80 |
| Shares Outstanding | 42.0 million (basic, 2026 Q2) |
Mira Pharmaceuticals Income Statement
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Pre-Tax Income | -$12.0M | -$7.9M | -$10.4M |
| Net Income | -$12.0M | -$7.9M | -$10.4M |
| Diluted EPS | -$0.64 | -$0.51 | -$1.35 |
Mira Pharmaceuticals Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Net Income | -$1.1M | -$6.0M | -$1.2M | -$1.2M |
| Diluted EPS | -$1.18 | — | -$0.03 | -$0.03 |
Mira Pharmaceuticals Balance Sheet
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Cash & Equivalents | — | — | $6.3M |
| Current Assets | $4.9M | $2.9M | $11.1M |
| Total Assets | $4.9M | $2.9M | $11.1M |
| Current Liabilities | $558,097 | $723,349 | $702,068 |
| Total Liabilities | $558,097 | $723,349 | $702,068 |
| Shareholders' Equity | $4.4M | $2.2M | $10.4M |
Mira Pharmaceuticals Cash Flow Statement
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Cash From Operations | -$4.5M | -$5.6M | -$4.7M |
| Cash From Financing | $8.8M | $3.8M | $8.2M |
| Free Cash Flow | -$4.5M | -$5.6M | -$4.7M |
Figures from Mira Pharmaceuticals' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Mira Pharmaceuticals financials page for every line item.
Mira Pharmaceuticals Company Profile
| Ticker | MIRA |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Miami, Florida |
| Incorporated in | Florida |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001904286 |
Frequently Asked Questions
What was Mira Pharmaceuticals' net income in fiscal 2025?
Mira Pharmaceuticals reported net income of -$10.4M for fiscal 2025.
What was Mira Pharmaceuticals' earnings per share (EPS) in fiscal 2025?
Mira Pharmaceuticals' diluted EPS was -$1.35 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Mira Pharmaceuticals generate in fiscal 2025?
Mira Pharmaceuticals generated -$4.7M of free cash flow in fiscal 2025.
How many shares of Mira Pharmaceuticals are outstanding?
Mira Pharmaceuticals reported a weighted average of 42.0 million basic shares outstanding in 2026 Q2.
What is Mira Pharmaceuticals' market cap?
Based on its latest closing price, Mira Pharmaceuticals (MIRA) has a market capitalization of about $28.0M.
Where is Mira Pharmaceuticals headquartered?
Mira Pharmaceuticals lists its business address in Miami, Florida in its SEC filings.